Blydt-Hansen, I.; Bech, M.; Jackson, S. Emicizumab in Severe Hemophilia A: Clinical and Patient Determinants of Transition Within a Standardized Program. J Hematol 2025, 14 (5), 257-261. https://doi.org/10.14740/jh2113.